Back to search

Article

Discernment of cerebral amyloid and cognitive status using ultrasensitive blood biomarkers collected with a non-traditional anticoagulant

2022-07-15

Abstract excerpt

<h4>Background: </h4> The development of biomarkers that are easy to collect, process, and store is a major goal of current Alzheimer’s Disease (AD) research, and underlies the growing interest in plasma biomarkers. Biomarkers with these qualities will improve confidence in diagnosis and allow for better monitoring of therapeutic interventions. However, blood collection strategies have historically differed betwee...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bf37f2db-1ff9-567f-9b2d-d2ba4f77ba34
DOI
10.21203/rs.3.rs-1828521/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discernment of cerebral amyloid and cognitive status using ultrasensitive blood biomarkers collected with a non-traditional anticoagulantDOI 10.21203/rs.3.rs-1828521/v1
Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity
Development and clinical validation of blood-based multibiomarker models for the evaluation of brain amyloid pathologySemantic proximity
Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity
Performance of Plasma Amyloid β, Total Tau and Neurofilament Light Chain Levels for Alzheimer’s Disease IdentificationSemantic proximity
Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real‐world population‐based cohortSemantic proximity
Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review.Semantic proximity
The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular eventsSemantic proximity
Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine ApproachSemantic proximity
Plasma vs. serum: which is better for proteomic blood biomarker analysis? Evaluation of the novel NULISA platformSemantic proximity
Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer’s Disease patients and cognitively normal individualsSemantic proximity
The association of blood-based biomarkers of neuropathology with cognitive performance and incident dementia in a diverse, nationally-representative sample of US adultsSemantic proximity
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s diseaseSemantic proximity
Select a neighboring publication to make it the new centre.